About Protyon
Protyon is a company based in Groningen (Netherlands) founded in 2022 by Rositsa Jordanova, Josef Melcr, and Hoang Nguyen. Protyon has raised $658.29 thousand across 1 funding round from investors including NVNOM and LUMO Labs. Protyon offers products and services including 3D Digital Model and Training Course. Protyon operates in a competitive market with competitors including GenomOncology, ONCOHOST, Geneseeq, Radialogica and Sipai Wangluo, among others.
- Headquarter Groningen, Netherlands
- Founders Rositsa Jordanova, Josef Melcr, Hoang Nguyen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Protyon Bv
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$658.29 K (USD)
in 1 rounds
-
Latest Funding Round
$658.29 K (USD), Seed
May 11, 2023
-
Investors
NVNOM
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Protyon
Protyon offers a comprehensive portfolio of products and services, including 3D Digital Model and Training Course.
Predicts interactions of drugs with cancer mutations for therapy selection.
Teaches clinicians molecular modeling for cancer treatment decisions.
Funding Insights of Protyon
Protyon has successfully raised a total of $658.29K through 1 strategic funding round. The most recent funding activity was a Seed round of $658.29 thousand completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Protyon
Protyon has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include NVNOM and LUMO Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Opportunities are created for impact-driven ventures in emerging technologies.
|
Locked | Locked | Locked | |
|
Management consulting and business management services are provided to clients.
|
Locked | Locked | Locked |
Investor details for Protyon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Protyon
Investment portfolio details for Protyon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Protyon
Detailed financials for Protyon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Protyon Comparisons
Peer comparison for Protyon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Protyon
Protyon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenomOncology, ONCOHOST, Geneseeq, Radialogica and Sipai Wangluo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic data is transformed into actionable insights for precision medicine.
|
|
| Locked | Locked | Locked |
AI-based proteomic analysis for oncology therapy planning is offered.
|
|
| Locked | Locked | Locked |
Personalized cancer treatments are delivered using genomic RNA profiling.
|
|
| Locked | Locked | Locked |
Decision support tools for radiation oncology are provided to clinicians.
|
|
| Locked | Locked | Locked |
Delivers big data aggregation and analytics solutions for oncology.
|
Detailed competitors of Protyon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Protyon
Complete news archive for Protyon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Protyon
Protyon was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Protyon is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.
Rositsa Jordanova is the current CEO of Protyon. They have also founded this company.
Protyon is a funded company, having raised a total of $658.29K across 1 funding round to date.
Protyon was established in 2022 in Groningen, Netherlands. Operations are focused on the biotechnology sector, where cancer therapeutics are developed through research and innovation processes. Training programs are offered to support professional development in oncology-related fields. Services encompass both therapeutic advancement and educational initiatives, with activities centered in the European healthcare landscape. Key leadership includes co-founders handling CEO, CTO, and CCO roles.
Protyon's top competitors include ONCOHOST, GenomOncology and Geneseeq.
Protyon offers 3D Digital Model and Training Course.